Latest Vertex Pharmaceuticals News & Updates

See the latest news and media coverage for Vertex. We track all announcements, press releases, and industry mentions in real time, all in one place.

Vertex Pharmaceuticals (Vertex)

Biopharmaceutical company

vrtx.com

Headquarters: Boston, United States
Founded year: 1989
Company type: Public company
Number of employees: 6,000–10,000

Last updated Today

Latest news about Vertex Pharmaceuticals (Vertex)

In short: Vertex reported strong Q1 2026 revenue of $2.99 billion and achieved significant regulatory milestones for its kidney and pain management therapies.

Company announcements

June 11 Vertex

Vertex presents new CASGEVY data in children 5–11

Data from pivotal studies show transformative potential consistent with older patients; regulatory submissions made in US, Saudi Arabia, and UK.

June 1 Vertex

Vertex announces US FDA acceptance of BLA for povetacicept

The FDA set a PDUFA date of November 30, 2026, for accelerated approval in IgA nephropathy.

May 6 Vertex

Vertex announces CASGEVY reimbursement agreement in Germany

The deal with GKV-Spitzenverband ensures access for patients 12+ with sickle cell disease or transfusion-dependent beta thalassemia.

May 4 Vertex

Vertex reports Q1 2026 financial results

Total revenue reaches $2.99 billion, up 8% from 2025. Reiterates full-year guidance of $12.95-13.1 billion. Pipeline advances include povetacicept BLA submission.

Media coverage

June 16 Sickle Cell Disease News

FDA reviewing Casgevy for children with sickle cell as young as 5

U.S. regulators are reviewing a label expansion for Casgevy that would cover children with sickle cell disease as young as 5.

June 14 MSN

Vertex raises 2025 revenue guidance to $12B with strong launches and pipeline progress

Q1 2025 Management View CEO Reshma Kewalramani highlighted $2.77 billion in revenue for Q1 2025, reflecting 3% growth compared to the prior year. The company...

June 13 The Globe and Mail

Vertex Pharmaceuticals (VRTX) Receives a Buy from Wells Fargo

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

June 12 Yahoo Finance

Vertex Extends Pediatric Pipeline As Shares Trade Below Consensus Targets

Vertex Pharmaceuticals reported pivotal pediatric data for CASGEVY for young children with severe sickle cell disease and beta thalassemia. The company released positive long term...

Never miss news about Vertex

Track Vertex and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.